Medisetty MK, Patel A, Pujari S. Letter to the editor on "Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial" by Udwadia Z et al. Int J Infect Dis 2021 Feb 15. pii: S1201-9712(21)00121.
PMID: 33601033